Clinical Trial Update: Amprenavir/Ritonavir, Saquinavir/Ritonavir or Efavirenz in HIV-Infected Subjects Following Failure With Kaletra (ABT-378/Ritonavir) as Their First Protease Inhibitor Based HAART [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluated amprenavir/ritonavir, saquinavir/ritonavir, or efavirenz in HIV-infected subjects who failed Kaletra as their first protease inhibi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Agenerase (amprenavir)
• Invirase (saquinavir)
• Norvir (ritonavir)
• Sustiva (efavirenz)

Snippet

Sponsor: Abbott | Conditions: HIV Infections | Phase 2 | Status: COMPLETED